NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-54.03%
Change (1 year)
Categories
NGM Biopharmaceuticals (NGM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $20.23 M
According to NGM Biopharmaceuticals's latest financial reports the company's total liabilities are $20.23 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
NGM Biopharmaceuticals - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $20.23 M | -57.71% |
| 2022-12-31 | $47.84 M | -28.32% |
| 2021-12-31 | $66.74 M | 36.2% |
| 2020-12-31 | $49 M | -1.38% |
| 2019-12-31 | $49.68 M | -85.98% |
| 2018-12-31 | $0.35 B | -4.23% |
| 2017-12-31 | $0.36 B | -5.65% |
| 2016-12-31 | $0.39 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.62 B | 2,977.01% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.01 M | -40.63% | 🇺🇸 USA |